Individual Narratives of Stimulation (ECT and TMS)
INSight
Lived Experience of People Who Have Received Both Electroconvulsive Therapy (ECT) and Transcranial Magnetic Stimulation (TMS) for Treating Major Depressive Disorder: a Narrative Inquiry
1 other identifier
observational
12
1 country
2
Brief Summary
Electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) are two evidence-based treatments for major depressive disorder. Both work by stimulating the brain (a process known as neuromodulation), but they differ markedly in invasiveness. ECT requires a general anaesthetic, whereas TMS is delivered while a person is awake and alert and they can go home immediately afterwards. TMS has been proposed as an alternative to ECT for some people. However, TMS is not as effective as ECT in all cases, is generally slower acting, and remains less widely available. In Nottingham and Liverpool, there are a small number of individuals who have experienced both ECT and TMS across different episodes of depression. Whilst previous studies have explored experiences of ECT and TMS separately, often using relatively superficial methods, none have examined the perspectives of people who have received both treatments. This study addresses that gap through an in-depth exploration of their experiences. The investigators will use a narrative inquiry approach that encourages participants to tell the story of their experiences of ECT and TMS in their own words. Eligible participants will be adults who have previously received both treatments for depression. Participation involves four sessions: a structured discussion to map the timeline of their depression and treatments, two in-depth open-ended interview sessions (narrative inquiry), and a follow-up discussion about the researchers' reconstruction of their story. Recruitment will take place through services in Nottingham and Liverpool. This study will help to understand how patients relate to, and make sense of, ECT and TMS, which contextual factors shape their experiences, and how these treatments fit into broader recovery journeys. The findings will inform the development of patient-centred services, support shared decision-making, and help healthcare professionals deepen compassionate understanding of treatment experiences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2026
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2026
CompletedFirst Posted
Study publicly available on registry
September 8, 2026
CompletedStudy Start
First participant enrolled
November 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2027
Study Completion
Last participant's last visit for all outcomes
October 31, 2027
September 30, 2026
August 1, 2026
12 months
September 1, 2026
September 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Co-created narratives and associated themes
From enrollment to the completion of the follow-up feedback sesson
Study Arms (1)
People with lived experience of both ECT and TMS for treating major depression
Interventions
There is no intervention in this observation study (qualitative interviews about past treatment experiences)
Eligibility Criteria
Adults who have received at least one session of TMS in Nottingham or Liverpool, who have also received at least one session of ECT, both intended to treat an episode of major depression
You may qualify if:
- years or older
- Previously received at least one TMS and one ECT session as treatment for major depression
- Conversational in the English language
- Capacity to give informed consent to take part in this study
- Feels fully informed and well enough to be able to share potentially distressing past experiences
You may not qualify if:
- Participants may be excluded at the judgement of the PI if it is felt that the participant is at high risk of significant emotional distress from taking part in the interviews at this time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nottinghamlead
- Mersey Care NHS Trustcollaborator
Study Sites (2)
Mersey Care NHS Foundation Trust
Liverpool, United Kingdom
University of Nottingham
Nottingham, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul M Briley
University of Nottingham
- PRINCIPAL INVESTIGATOR
Jade Thai
Mersey Care NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2026
First Posted
September 8, 2026
Study Start (Estimated)
November 1, 2026
Primary Completion (Estimated)
October 31, 2027
Study Completion (Estimated)
October 31, 2027
Last Updated
September 30, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share